| Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors M Canale, E Petracci, A Delmonte, E Chiadini, C Dazzi, M Papi, L Capelli, ... Clinical Cancer Research 23 (9), 2195-2202, 2017 | 247 | 2017 |
| Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement E Solcia, R Fiocca, O Luinetti, L Villani, L Padovan, D Calistri, ... The American journal of surgical pathology 20, 8-22, 1996 | 221 | 1996 |
| Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer E Flamini, L Mercatali, O Nanni, D Calistri, R Nunziatini, W Zoli, P Rosetti, ... Clinical Cancer Research 12 (23), 6985-6988, 2006 | 163 | 2006 |
| Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with … S Salvi, V Casadio, V Conteduca, SL Burgio, C Menna, E Bianchi, L Rossi, ... British journal of cancer 112 (10), 1717-1724, 2015 | 143 | 2015 |
| p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. GN Ranzani, O Luinetti, LS Padovan, D Calistri, B Renault, M Burrel, ... Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1995 | 143 | 1995 |
| Relevance of urine telomerase in the diagnosis of bladder cancer MA Sanchini, R Gunelli, O Nanni, S Bravaccini, C Fabbri, A Sermasi, ... Jama 294 (16), 2052-2056, 2005 | 139 | 2005 |
| Cell-free DNA as a diagnostic marker for cancer: current insights S Salvi, G Gurioli, U De Giorgi, V Conteduca, G Tedaldi, D Calistri, ... Oncotargets and therapy, 6549-6559, 2016 | 130 | 2016 |
| Mutation analysis of p53, K‐ras, and BRAF genes in colorectal cancer progression D Calistri, C Rengucci, I Seymour, A Lattuneddu, A Polifemo, F Monti, ... Journal of cellular physiology 204 (2), 484-488, 2005 | 117 | 2005 |
| Fecal multiple molecular tests to detect colorectal cancer in stool D Calistri, C Rengucci, R Bocchini, L Saragoni, W Zoli, D Amadori Clinical Gastroenterology and Hepatology 1 (5), 377-383, 2003 | 112 | 2003 |
| Microsatellite instability and mutations of p53 and TGF-‚ RII genes in gastric cancer B Renault, D Calistri, G Buonsanti, O Nanni, D Amadori, GN Ranzani Human genetics 98, 601-607, 1996 | 110 | 1996 |
| GSTP1 methylation and protein expression in prostate cancer: diagnostic implications F Martignano, G Gurioli, S Salvi, D Calistri, M Costantini, R Gunelli, ... Disease markers 2016, 2016 | 106 | 2016 |
| Nonsquamous, non-small-cell lung cancer patients who carry a double mutation of EGFR, EML4-ALK or KRAS: frequency, clinical-pathological characteristics, and response to therapy P Ulivi, E Chiadini, C Dazzi, A Dubini, M Costantini, L Medri, M Puccetti, ... Clinical lung cancer 17 (5), 384-390, 2016 | 102 | 2016 |
| Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data V Casadio, D Calistri, M Tebaldi, S Bravaccini, R Gunelli, G Martorana, ... Urologic oncology: seminars and original investigations 31 (8), 1744-1750, 2013 | 99 | 2013 |
| Combined inhibition of CDK4/6 and PI3K/AKT/mTOR pathways induces a synergistic anti-tumor effect in malignant pleural mesothelioma cells MA Bonelli, G Digiacomo, C Fumarola, R Alfieri, F Quaini, A Falco, ... Neoplasia 19 (8), 637-648, 2017 | 97 | 2017 |
| p16INK4A and CDH13 hypermethylation in tumor and serum of non‐small cell lung cancer patients P Ulivi, W Zoli, D Calistri, F Fabbri, A Tesei, M Rosetti, M Mengozzi, ... Journal of cellular physiology 206 (3), 611-615, 2006 | 97 | 2006 |
| c-kit and SCF expression in normal and tumor breast tissue P Ulivi, W Zoli, L Medri, D Amadori, L Saragoni, F Barbanti, D Calistri, ... Breast cancer research and treatment 83, 33-42, 2004 | 91 | 2004 |
| Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer G Tedaldi, M Tebaldi, V Zampiga, R Danesi, V Arcangeli, M Ravegnani, ... Oncotarget 8 (29), 47064, 2017 | 87 | 2017 |
| Shifts of faecal microbiota during sporadic colorectal carcinogenesis G Mori, S Rampelli, BS Orena, C Rengucci, G De Maio, G Barbieri, ... Scientific reports 8 (1), 1-11, 2018 | 86 | 2018 |
| Multiple detection of genetic alterations in tumors and stool C Rengucci, P Maiolo, L Saragoni, W Zoli, D Amadori, D Calistri Clinical Cancer Research 7 (3), 590-593, 2001 | 84 | 2001 |
| Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer S Salvi, V Casadio, V Conteduca, C Lolli, G Gurioli, F Martignano, ... Oncotarget 7 (25), 37839, 2016 | 80 | 2016 |
